Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) EPS without NRI: ¥0.64 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:605033 Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
69 GF Score
Price ¥19.59
GF Value ¥22.03
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Shaanxi Meibang Pharmaceutical Group Co EPS without NRI?

Shaanxi Meibang Pharmaceutical Group Co SHSE:605033 +4.15% 69 EPS without NRI is ¥0.64 as of Jun. 2026. GuruFocus rates SHSE:605033 with a GF Score™ of 69/100 and a GF Value™ of ¥22.03 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 214 Agriculture companies, Shaanxi Meibang Pharmaceutical Group Co ranks worse than 85.51% on this metric.

Shaanxi Meibang Pharmaceutical Group Co's earnings per share without non-recurring items for the three months ended in Jun. 2026 was ¥0.18. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2026 was ¥0.64.

During the past 12 months, Shaanxi Meibang Pharmaceutical Group Co's average earnings per share (NRI) Growth Rate was 153.80% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -33.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -29.00% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Shaanxi Meibang Pharmaceutical Group Co's EPS without NRI or its related term are showing as below:

SHSE:605033' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -45.9   Med: -12.15   Max: 11.5
Current: -33.1

During the past 9 years, Shaanxi Meibang Pharmaceutical Group Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 11.50% per year. The lowest was -45.90% per year. And the median was -12.15% per year.

SHSE:605033's 3-Year EPS without NRI Growth Rate is ranked worse than
85.51% of 214 companies
in the Agriculture industry
Industry Median: -3.75 vs SHSE:605033: -33.10

Shaanxi Meibang Pharmaceutical Group Co's EPS (Diluted) for the three months ended in Jun. 2026 was ¥0.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ¥0.47.

Shaanxi Meibang Pharmaceutical Group Co's EPS (Basic) for the three months ended in Jun. 2026 was ¥0.12. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was ¥0.47.


Shaanxi Meibang Pharmaceutical Group Co  (SHSE:605033) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Shaanxi Meibang Pharmaceutical Group Co EPS without NRI Related Terms


Shaanxi Meibang Pharmaceutical Group Co EPS without NRI Historical Data

* Premium members only.

The historical data trend for Shaanxi Meibang Pharmaceutical Group Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shaanxi Meibang Pharmaceutical Group Co EPS without NRI Chart

Shaanxi Meibang Pharmaceutical Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only 1.01 0.97 0.31 0.16 0.29

Shaanxi Meibang Pharmaceutical Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 -0.04 0.18 0.32 0.18

SHSE:605033 vs CTVA, CF, MOS: EPS without NRI Comparison

For the Agricultural Inputs subindustry, Shaanxi Meibang Pharmaceutical Group Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shaanxi Meibang Pharmaceutical Group Co PE Ratio without NRI vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Shaanxi Meibang Pharmaceutical Group Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Shaanxi Meibang Pharmaceutical Group Co's PE Ratio without NRI falls into.


SHSE:605033
69GF Score
Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shaanxi Meibang Pharmaceutical Group Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of ¥0.64 mean?
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a EPS without NRI of ¥0.64 as of Jun. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. According to the industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #183 out of 214 companies in the Agriculture industry, placing it in the top 85.5%.
Is Shaanxi Meibang Pharmaceutical Group Co's EPS without NRI too high?
Shaanxi Meibang Pharmaceutical Group Co's current EPS without NRI is ¥0.64. Based on the distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #183 out of 214 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's EPS without NRI compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #183 out of 214 companies for EPS without NRI. This places Shaanxi Meibang Pharmaceutical Group Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Agriculture company?
A good EPS without NRI depends on the Agriculture industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. Shaanxi Meibang Pharmaceutical Group Co's current EPS without NRI is ¥0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.03, compared to a current price of ¥19.59 — trading 11.1% below its estimated fair value. The current EPS without NRI is ¥0.64. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current EPS without NRI is ¥0.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?

Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥19.59 is trading 11.1% below its estimated GF Value™ of ¥22.03. GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:605033:

  • EPS without NRI: ¥0.64
  • GF Value™: ¥22.03 vs. price of ¥19.59 (11.1% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shaanxi Meibang Pharmaceutical Group Co Business Description

Address High-tech Industrial Development Zone, Pucheng County, Shaanxi Province, Weinan, CHN, 715500
Shaanxi Meibang Pharmaceutical Group Co Ltd is engaged in the research and development, production and sales of pesticide formulations.
69GF Score

Get the complete analysis for SHSE:605033

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.59
Price
¥22.03
GF Value